After an abdominal surgery led to a cancer diagnosis, Princess Kate Middleton has embarked on a preventative chemotherapy journey, spotlighting the essential aspects of cancer care and prevention.
Princess Kate Middleton has commenced “preventative chemotherapy” following a diagnosis of cancer, which was identified after she underwent abdominal surgery. The term “preventative chemotherapy” is not officially recognized by the NHS but is understood to refer to chemoprevention aimed at reducing cancer risk or preventing its recurrence. Chemotherapy treatment, in general, targets the elimination of cancer cells, preventing them from multiplying within the body.
There are multiple forms of chemotherapy, including adjuvant therapy to eliminate remaining cancer cells post-surgery, neo-adjuvant therapy to reduce tumors before surgery, and palliative therapy to ease symptoms in advanced cancer stages. Additionally, the World Health Organisation utilizes “preventive chemotherapy” in a public health context, treating populations to prevent diseases like lymphatic filariasis.
In 2021-22, over 320,000 patients received cancer treatment through the NHS, highlighting the significance of addressing cancer. With Princess Kate’s treatment journey underway, attention is drawn to the critical role of cancer treatment and prevention methods.